CClinicalTrials.gg
Enrolling by invitationNCT06946186VSCUpdated Jul 17, 2026

Virtual Senior Center

An interventional study of Virtual Senior Center - GrandPad and Virtual Senior Center - No GrandPad in Social Isolation in Older Adults, Quality of Life (QOL) and Activities of Daily Living, sponsored by Washington University School of Medicine. Enrolling by invitation at 1 site in United States. Open to participants aged 65 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-17.

Sponsored by Washington University School of Medicine · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
650
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Study summary

In a 3-group trial with randomization and follow-up for 12 months, we will compare use of the VSC as well as health and quality of life outcomes among 650 older adults in St. Louis who receive either: (1) home delivered meals AND a GrandPad; (2) home-delivered meals but no GrandPad for 6 months; and (3) in person meals at senior center but no GrandPad.

Read the detailed description

The aims of the study are:

  1. Recruit 650 older adults in St. Louis into the study - 400 home-delivered meal recipients and 250 receiving in-person meals at senior centers. Describe baseline differences between the two groups in use of senior center programming, technology access and use, and health and quality of life outcomes.
  2. Randomly assign the 400 home-delivered meal recipients to get a GrandPad immediately (GP) or 6 months later (GP-6). Compare the GP and GP-6 groups to in-person meal recipients (IP) on: (A) VSC engagement at 6- and 12-month follow-up; and (B) health and quality of life outcomes at 6- and 12-month follow-up.
  3. Examine longitudinal changes and hypothesized mediating pathways using 5 waves of data from baseline, 3-,6-,9- and 12-month follow-up. Specifically: (A) in the GP-6 group only, compare VSC engagement, health and quality of life outcomes at 6-month follow-up (a period in which they did not have a GrandPad) to 12-month follow-up (a period in which they did have a GrandPad); (B) examine 12-month trends in GrandPad and VSC engagement, health and quality of life outcomes within and across groups; and (C) test mediation of hypothesized explanatory variables from the study's conceptual framework to examine potential causal pathways for health and quality of life outcomes.
02

Conditions studied

  • Social Isolation in Older Adults
  • Quality of Life (QOL)
  • Activities of Daily Living

Keywords

  • digital access for older adults
03

In context

Lead sponsor

Washington University School of Medicine is the lead sponsor of 1,765 studies on the registry; 271 are open to participants now.

Of its 324 completed or terminated interventional studies of FDA-regulated products, 212 (65%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Current Home-delivered meal client with Aging Ahead

Exclusion criteria

Exclusion Criteria:

  • Under age 65
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
650 participants (estimated)

Study arms

  • Experimental
    GrandPad1

    This group will receive a GrandPad right away after they complete the baseline survey

    Behavioral: Virtual Senior Center - GrandPad

  • Other
    GrandPad2 - 6mo

    Delayed interventional. This group will receive a GrandPad after 6 months.

    Behavioral: Virtual Senior Center - GrandPad

  • Active comparator
    Congregate

    This group will not receive a GrandPad but will get access to the Virtual Senior Center

    Behavioral: Virtual Senior Center - No GrandPad

Interventions

  • BehavioralVirtual Senior Center - GrandPad

    The Virtual Senior Center engages older adults in programs and services online with the help of a GrandPad.

  • BehavioralVirtual Senior Center - No GrandPad

    Participants will be given information to access the website when they are able from their own phone, tablet, or computer.

06

What researchers measure

Primary outcomes

  1. The Social Isolation Scale in Older Adults (Nicholson et al., 2020; The Gerontologist)

    This 6-item questionnaire measures the extent to which an individual feels socially unconnected, using 2 related constructs (3 items per construct): quantity of social contacts and sense of relationship. The response options for social contacts ranges from 1 (none) to 5 (6 or more) and the sense of relationship ranges from 1(strongly disagree) to 5 (strongly agree). The possible summed scores range from 6 to 30, with higher scores indicating less social isolation.

    Time frame: 12 month

Secondary outcomes

  1. Digital Social Participation (Anderberg et al., 2021; JMIR)

    This 6-item questionnaire measures extent to which someone feels that digital technology is beneficial in their life. Response options range from 1 (strongly disagree) to 5 (strongly agree), so total summed scores range from 6 -30. A higher scores indicates more positive perceptions of digital technology.

    Time frame: 12 month

07

Study locations

1 site
  • Washington University
    St Louis, Missouri 63101, United States
08

References and documents

Individual participant data

Plan to share: Yes — The raw survey response data including dates collected, as well as participant ID codes generated for this study will be shared in order to link the five waves of survey data as well as documentation of participation. All respondent identifiers (e.g., names, addresses) will be removed before sharing. Final de-identified intervention data and Common Survey 4 data will be shared with the CEAL (community engagement Alliance) Technical Assistance Team. Other CEAL researchers will be allowed to request common survey data. We will share all publicly accessible files on WashU Research Data, an institutional repository managed by the Washington University in St. Louis Libraries that uses a cloud-based hosted repository service called TIND as its platform. TIND is based on the open-source Invenio software developed at the research institute CERN to manage its own scholarly output. TIND uses an OAIS-compliant approach to preservation, with redundancy backup, conversion to archival file format

Supporting information: Analytic code

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06946186
Lead sponsor
Washington University School of Medicine
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Responsible party
Matthew Kreuter (Kahn Family Professor, Washington University School of Medicine) — Principal investigator
First posted
Apr 27, 2025
Start date
Apr 23, 2025
Primary completion
Dec 2027 (estimated)
Completion
Jan 2028 (estimated)
Last update
Jul 17, 2026

Study contacts

Matthew Kreuter, PhD, MPH
principal investigator · Washington University School of Medicine

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion